Found: 71
Select item for more details and to access through your institution.
Phase III trial of standard versus dose-intensified doxorubicin, ifosfamide and dacarbazine (MAID) in the first-line treatment of metastatic and locally advanced soft tissue sarcoma.
- Published in:
- Investigational New Drugs, 2009, v. 27, n. 5, p. 482, doi. 10.1007/s10637-008-9217-1
- By:
- Publication type:
- Article
<italic>RREB1–MKL2</italic> fusion in biphenotypic “oropharyngeal” sarcoma: New entity or part of the spectrum of biphenotypic sinonasal sarcomas?
- Published in:
- Genes, Chromosomes & Cancer, 2018, v. 57, n. 4, p. 203, doi. 10.1002/gcc.22521
- By:
- Publication type:
- Article
Real-life patterns of use, safety and effectiveness of sunitinib in first-line therapy of metastatic renal cell carcinoma: the SANTORIN cohort study.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2017, v. 26, n. 12, p. 1561, doi. 10.1002/pds.4228
- By:
- Publication type:
- Article
Intermediate analysis of a phase II trial assessing gemcitabine and cisplatin in locoregional or metastatic penile squamous cell carcinoma.
- Published in:
- BJU International, 2016, v. 117, n. 3, p. 444, doi. 10.1111/bju.13054
- By:
- Publication type:
- Article
Erratum.
- Published in:
- International Journal of Cancer, 2007, v. 120, n. 2, p. 450, doi. 10.1002/ijc.22109
- By:
- Publication type:
- Article
Docetaxel and gemcitabine combination in 133 advanced soft-tissue sarcomas: A retrospective analysis.
- Published in:
- International Journal of Cancer, 2006, v. 119, n. 3, p. 706, doi. 10.1002/ijc.21867
- By:
- Publication type:
- Article
Determining the Length of Posttherapeutic Follow-up for Cancer Patients Using Competing Risks Modeling.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
A V530I Mutation in c-KIT Exon 10 Is Associated to Imatinib Response in Extraabdominal Aggressive Fibromatosis.
- Published in:
- 2010
- By:
- Publication type:
- Case Study
Management and outcomes of adolescent and young adult sarcoma patients: results from the French nationwide database NETSARC.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-10556-4
- By:
- Publication type:
- Article
ASO Visual Abstract: Initial Active Surveillance Strategy for Patients with Peripheral Sporadic Primary Desmoid-Type Fibromatosis: A Multicentric Phase II Observational Trial.
- Published in:
- 2023
- By:
- Publication type:
- Abstract
Initial Active Surveillance Strategy for Patients with Peripheral Sporadic Primary Desmoid-Type Fibromatosis: A Multicentric Phase II Observational Trial.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2023, v. 30, n. 13, p. 8653, doi. 10.1245/s10434-023-14341-2
- By:
- Publication type:
- Article
Pharmacokinetic and Pharmacogenetic Study of Etoposide in High-Dose Protocol (TI-CE) for Advanced Germ Cell Tumors.
- Published in:
- Pharmaceutical Research, 2020, v. 37, n. 7, p. 1, doi. 10.1007/s11095-020-02861-5
- By:
- Publication type:
- Article
Regorafenib in patients with advanced Ewing sarcoma: results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre Phase II study.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 12, p. 1940, doi. 10.1038/s41416-023-02413-9
- By:
- Publication type:
- Article
Spatio-temporal genetic heterogeneity of CTNNB1 mutations in sporadic desmoid type fibromatosis lesions.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Association between clinically relevant toxicities of pazopanib and sunitinib and the use of weak CYP3A4 and P-gp inhibitors.
- Published in:
- European Journal of Clinical Pharmacology, 2020, v. 76, n. 4, p. 579, doi. 10.1007/s00228-020-02828-w
- By:
- Publication type:
- Article
PARP1 expression in soft tissue sarcomas is a poor‐prognosis factor and a new potential therapeutic target.
- Published in:
- Molecular Oncology, 2019, v. 13, n. 7, p. 1577, doi. 10.1002/1878-0261.12522
- By:
- Publication type:
- Article
Value of peri-operative chemotherapy in patients with CINSARC high-risk localized grade 1 or 2 soft tissue sarcoma: study protocol of the target selection phase III CHIC-STS trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Geographic Tongue Induced by Angiogenesis Inhibitors.
- Published in:
- 2013
- By:
- Publication type:
- Letter
Sorafenib for Patients with Advanced Angiosarcoma: A Phase II Trial from the French Sarcoma Group (GSF/GETO)
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Sorafenib for Patients with Advanced Angiosarcoma: A Phase II Trial from the French Sarcoma Group (GSF/GETO).
- Published in:
- Oncologist, 2012, v. 17, n. 2, p. 260, doi. 10.1634/theoncologist.2011-0237
- By:
- Publication type:
- Article
HFS-14, a Specific Quality of Life Scale Developed for Patients Suffering from Hand-Foot Syndrome.
- Published in:
- Oncologist, 2011, v. 16, n. 10, p. 1469, doi. 10.1634/theoncologist.2011-0033
- By:
- Publication type:
- Article
Outcome of 449 adult patients with rhabdomyosarcoma: an observational ambispective nationwide study.
- Published in:
- Cancer Medicine, 2018, v. 7, n. 8, p. 4023, doi. 10.1002/cam4.1374
- By:
- Publication type:
- Article
How to improve adherence of guidelines for localized testicular cancer surveillance: A Delphi consensus study.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1036190
- By:
- Publication type:
- Article
Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first-line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Rhabdomyosarcoma associated with germline TP53 alteration in children and adolescents: The French experience.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Prognostic factors of response or failure of treatment in patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Français d’Immunothérapie.
- Published in:
- World Journal of Urology, 2005, v. 23, n. 3, p. 161, doi. 10.1007/s00345-004-0467-z
- By:
- Publication type:
- Article
Breslow thickness, clark index and ulceration are associated with sentinel lymph node metastasis in melanoma patients: a cohort analysis of 612 patients.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Breslow Thickness, Clark Index and Ulceration Are Associated with Sentinel Lymph Node Metastasis in Melanoma Patients: A Cohort Analysis of 612 Patients.
- Published in:
- Dermatology (10188665), 2014, v. 229, n. 3, p. 183, doi. 10.1159/000362902
- By:
- Publication type:
- Article
Development of Papulopustular Rosacea during Nivolumab Therapy for Metastatic Cancer.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
Paronychia and Pyogenic Granuloma Induced by New Anticancer mTOR Inhibitors.
- Published in:
- Acta Dermato-Venereologica, 2011, v. 91, n. 5, p. 584, doi. 10.2340/00015555-1097
- By:
- Publication type:
- Article
REGOSARC: Regorafenib versus placebo in doxorubicin-refractory soft-tissue sarcoma-A quality-adjusted time without symptoms of progression or toxicity analysis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Prognostic factors and impact of adjuvant treatments on local and metastatic relapse of soft-tissue sarcoma patients in the competing risks setting.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 21, p. 3361, doi. 10.1002/cncr.28885
- By:
- Publication type:
- Article
Long-term recurrence of soft tissue sarcomas: Prognostic factors and implications for prolonged follow-up.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 19, p. 3003, doi. 10.1002/cncr.28836
- By:
- Publication type:
- Article
Sorafenib in patients with progressive epithelioid hemangioendothelioma: A phase 2 study by the French Sarcoma Group (GSF/GETO)
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Sorafenib in patients with progressive epithelioid hemangioendothelioma Sorafenib in patients with progressive epithelioid hemangioendothelioma: A phase 2 study by the French Sarcoma Group (GSF/GETO).
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 14, p. 2639, doi. 10.1002/cncr.28109
- By:
- Publication type:
- Article
Comparison of doxorubicin and weekly paclitaxel efficacy in metastatic angiosarcomas.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 13, p. 3330, doi. 10.1002/cncr.26599
- By:
- Publication type:
- Article
Medroxyprogesterone, interferon alfa-2a, interleukin 2, or combination of both cytokines in patients with metastatic renal carcinoma of intermediate prognosis: results of a randomized controlled trial.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Multicentric phase II trial of TI‐CE high‐dose chemotherapy with therapeutic drug monitoring of carboplatin in patients with relapsed advanced germ cell tumors.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 7, p. 2250, doi. 10.1002/cam4.3687
- By:
- Publication type:
- Article
Serum creatine kinase increase in patients treated with tyrosine kinase inhibitors for solid tumors.
- Published in:
- Medical Oncology, 2012, v. 29, n. 4, p. 3003, doi. 10.1007/s12032-012-0204-1
- By:
- Publication type:
- Article
Correction to: Elbow flexion reconstruction after arm-sparing excision for high-grade triton sarcoma: a case report.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Elbow flexion reconstruction after arm-sparing excision for high-grade triton sarcoma: a case report.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Do Patients With Advanced Urothelial Carcinoma Benefit From Weekly Paclitaxel Chemotherapy? A GETUG Phase II Study.
- Published in:
- Clinical Genitourinary Cancer, 2009, v. 7, n. 2, p. E28, doi. 10.3816/CGC.2009.n.018
- By:
- Publication type:
- Article
The off-label use of targeted therapies in sarcomas: the OUTC'S program.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Refining the Characterization and Outcome of Pathological Complete Responders after Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: Lessons from the Randomized Phase III VESPER (GETUG-AFU V05) Trial.
- Published in:
- Cancers, 2023, v. 15, n. 6, p. 1742, doi. 10.3390/cancers15061742
- By:
- Publication type:
- Article
Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients with No Progression and with No More than Five Residual Metastatic Lesions Following First-Line Systemic Therapy: A Retrospective Analysis.
- Published in:
- Cancers, 2023, v. 15, n. 4, p. 1161, doi. 10.3390/cancers15041161
- By:
- Publication type:
- Article
Distinct Cellular Origins and Differentiation Process Account for Distinct Oncogenic and Clinical Behaviors of Leiomyosarcomas.
- Published in:
- Cancers, 2023, v. 15, n. 2, p. 534, doi. 10.3390/cancers15020534
- By:
- Publication type:
- Article
Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitors in the Treatment of Advanced Renal Cancer.
- Published in:
- Cancers, 2023, v. 15, n. 1, p. 313, doi. 10.3390/cancers15010313
- By:
- Publication type:
- Article
No Geographical Inequalities in Survival for Sarcoma Patients in France: A Reference Networks' Outcome?
- Published in:
- Cancers, 2022, v. 14, n. 11, p. 2620, doi. 10.3390/cancers14112620
- By:
- Publication type:
- Article
Pharmacogenetic Study of Trabectedin-Induced Severe Hepatotoxicity in Patients with Advanced Soft Tissue Sarcoma.
- Published in:
- Cancers, 2020, v. 12, n. 12, p. 3647, doi. 10.3390/cancers12123647
- By:
- Publication type:
- Article
The off-label use of targeted therapies in sarcomas: the OUTC'S program.
- Published in:
- BMC Cancer, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2407-14-870
- By:
- Publication type:
- Article